Qyuns Therapeutics Co., Ltd. (HKG:2509)
Hong Kong · Delayed Price · Currency is HKD 16.24
-0.18 (-1.10%)
Sep 11, 2026, 4:08 PM HKT
Qyuns Therapeutics Revenue
Qyuns Therapeutics had revenue of 424.06M CNY in the half year ending June 30, 2026, with 844.05% growth. This brings the company's revenue in the last twelve months to 1.02B, up 219.81% year-over-year. In the year 2025, Qyuns Therapeutics had annual revenue of 806.96M with 408.18% growth.
Revenue (ttm)
1.02B CNY
Revenue Growth
+219.81%
P/S Ratio
3.10
Revenue / Employee
2.90M CNY
Employees
353
Market Cap
3.67B HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 806.96M | 648.17M | 408.18% |
| Dec 31, 2024 | 158.79M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 9.66M | -11.69M | -54.74% |
| Dec 31, 2021 | 21.35M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Viva Biotech Holdings | 2.20B |
| Ocumension Therapeutics | 1.08B |
| Jacobio Pharmaceuticals Group | 852.85M |
| Medtide | 635.93M |
| BioDlink International Company | 582.45M |
| Mirxes Holding Company | 166.32M |
| TransThera Sciences (Nanjing) | 40.93M |
| HJ Science | 16.30M |